19.12.2014 - We took a look back at 2014: which European Biotechnology News stories topped the charts this year?
European Biotechnology News has delved into 2014’s archives and analysed the click-statistics, and pulled out the shakers and makers from the last twelve months.
It has been a good year for biotech IPOs – news stories on companies going public were highly popular, and the industry report detailing the new IPO boom even made the top three. However, the click record goes to pharma for the third year in a row, with Novartis dominating the most popular headlines.
16.12.2014 Two consortia combined of 144 European companies, research institutes and universities have been selected for funding by the EIT in the areas of health and raw materials. Both clusters are set to acquire €1.1bn over the next seven years.
10.12.2014 When it comes to the biggest investors in Research and Development (R&D) Swiss pharma top dogs Novartis and Roche have defended their positioning among the top ten companies worldwide – according to a recently published EU study.
05.12.2014 Austrian contract research company VTU has entered into a development and commercialisation agreement with US company RCT. The partners want to combine both companies' Pichia pastoris protein production technologies under VTU's roof.
03.12.2014 Danish biotech pharma Ascendis has successfully completed a €48m Series D financing round. The funding is expected to support its late-stage clinical trials to push its lead drug into Phase III trials.